FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2231931 · Received September 1, 2011

Report

Report Number
2024168-2011-06099
Event Type
Injury
Date Received
September 1, 2011
Date of Event
August 8, 2011
Report Date
August 9, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. DATE ESTIMATED. THERE WAS NO REPORTED PRODUCT DEFICIENCY AND THE PRODUCT WAS NOT RETURNED. RESTENOSIS IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP, IF ANY, TO THE DEVICE CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT 99% IN-STENT RESTENOSIS OF A XIENCE V STENT IN THE PROXIMAL CIRCUMFLEX ARTERY WITH MILD TORTUOSITY. THE 2.5 X 12 MM TREK BALLOON WAS ADVANCED; HOWEVER, COULD NOT CROSS THE RE-STENOSIS. A NON-ABBOTT BALLOON WAS USED FOR DILATATION, AND A SECOND ATTEMPT WAS MADE TO ADVANCE THE TREK, BUT THE BALLOON WAS UNABLE TO CROSS. A NON-ABBOTT BALLOON WAS USED FOR FURTHER DILATATION, AND A XIENCE V STENT WAS IMPLANTED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention